Newsletter

Pompe Disease
With one marketed therapy, and several in pipeline, Pompe disease market is anticipated to boost in the coming decade

More Newsletters

Evolution of Precision Medicine in Oncology Whitepaper
Evolution of Precision Medicine in Oncology

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and..

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required..

Cancer Globally (Vol. 1, Issue 1) Newsletter
Cancer Globally (Vol. 1, Issue 1)

Cancer has gripped the human society in its clutches in such a way that there has been many advancements to treat the same, but with little success.

Impact of BREXIT on Pharma Space Newsletter
Impact of BREXIT on Pharma Space

BREXIT, the 'EXIT' of 'BRITAIN' from 'EUROPEAN UNION', shook the whole world when the United Kingdom voted in the favor of leaving the EU.

Generalized Myasthenia Gravis Newsletter
Generalized Myasthenia Gravis

Myasthenia Gravis is a chronic autoimmune neuromuscular disease responsible for weakness in the skeletal muscles..